Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder
← Find more feeds

pfizer.com

https://www.pfizer.com/newsfeed

Get the latest updates from https://www.pfizer.com/newsfeed directly as they happen.

Follow now 230 followers

Latest posts

Last updated over 1 year ago

Pfizer to Acquire Biohaven Pharmaceuticals

over 1 year ago

Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis

over 1 year ago

Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer at ESMO Breast Cancer 2022

over 1 year ago

Pfizer Reports First-Quarter 2022 Results

over 1 year ago

Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies

over 1 year ago

Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer

over 1 year ago

Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVIDTM for Post-Exposure Prophylactic Use

over 1 year ago

Pfizer Announces 2022 Shareholder Meeting Preliminary Results

over 1 year ago

Pfizer Declares Second-Quarter 2022 Dividend

over 1 year ago

Pfizer to Open First U.S. Sites in Phase 3 Trial of Investigational Gene Therapy for Ambulatory Patients with Duchenne Muscular Dystrophy

over 1 year ago

Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine

over 1 year ago

Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age

over 1 year ago

Sign up to continue

Try Feeder for free

Everything you care about in one place

Try Feeder now